Tucows Inc: Form 10-Q for the period ended Jun 30, 2023
Filed with the SEC on Aug 3, 2023 and accepted by EDGAR at Aug 3, 2023, 17:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-01 to 2023-06-30 | $85.0m | us-gaap:Revenues |
| Revenue | 6 months2023-01-01 to 2023-06-30 | $165.4m | us-gaap:Revenues |
| Cost of revenue | 3 months2023-04-01 to 2023-06-30 | $66.9m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-01-01 to 2023-06-30 | $133.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-04-01 to 2023-06-30 | $18.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-06-30 | $32.1m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-01 to 2023-06-30 | $4.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-06-30 | $9.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-01 to 2023-06-30 | −$13.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-06-30 | −$30.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-01 to 2023-06-30 | −$3.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-06-30 | −$4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-01 to 2023-06-30 | −$31.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-06-30 | −$50.1m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2023-04-01 to 2023-06-30 | −$2.86 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-06-30 | −$4.63 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-01 to 2023-06-30 | 10,836,652 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-06-30 | 10,821,608 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-04-01 to 2023-06-30 | −$1.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Operating cash flow | 6 months2023-01-01 to 2023-06-30 | −$6.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-04-01 to 2023-06-30 | $23.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Capital expenditure | 6 months2023-01-01 to 2023-06-30 | $54.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-06-30 | $147.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-06-30 | $308.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-06-30 | $843.3m | us-gaap:Assets |
| Current liabilities | At period end2023-06-30 | $194.1m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2023-06-30 | $229.9m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2023-06-30 | $51.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-23-021981. Last ingested by Listed: Oct 27, 2026, 09:55 ET. Listed shows no prices and gives no investment advice.